| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.55 | 0.008 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |